Organon & Co. Price Today
Organon & Co.
OGN
Healthcare
$5.49B
💰
Market Cap
7.3
💸
Price to Earnings
$3.0
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
1 |
Hold |
5 |
Sell |
1 |
Strong Sell |
0 |
OGN Price Forecast Target
21.5 👉 43.0 +100%
OGN EPS Forecast
3.0 👉 4.6 +56%
Financials
Profit Margin
12 %
Revenue Growth
-1.9 %
Dividend
$ 1.12
Held Percent
0.1% - Insiders
79.8% - Institutions
20.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $745.0M
-
💰 Blackrock Inc. $381.7M
-
💰 Mawer Investment Management Ltd. $312.2M
-
💰 State Street Corporation $301.8M
-
💰 Massachusetts Financial Services Co. $196.7M
Stock Ideas
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly conc…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…📮FAQ
Some Frequently Asked Questions.
The Organon & Co. industry is Drug Manufacturers—General
The Organon & Co. sector is Healthcare
The Organon & Co. forecasted predicted Price to Earnings PE ratio is 4.7
The Organon & Co. Price to Earnings PE ratio is 7.3
The Market Capitalization of Organon & Co. is $5.49B
There are total of 254689357 float shares with 79.8% held by Institutions and 0.1% held by insiders
The MOrganon & Co. forecasted Earnings per Share EPS is $4.6
The Organon & Co. Earnings per Share EPS is 3.0
The Organon & Co. company has $3889000000 gross profits with 12 profit margins
The Organon & Co. Earnings Growth is -0.493% with -0.491% quarterly earnings growth
The Organon & Co. Revenue is $6144999936 with -0.019 revenue growth
The price target for Organon & Co. stock is $43.0 for the high target and $23.0 for the low target
The consensus analyst recommendations for Organon & Co. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Organon & Co. is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
The Beta of Organon & Co. is 0.8
The dividend of Organon & Co. is $1.12
The dividend yield of Organon & Co. is 0.051999997%
The biggest institutional and mutual fund holders of Organon & Co. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Mawer Investment Management Ltd.
- State Street Corporation
The Organon & Co. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0